NCT01790503 A Phase 1b/2 Study of PLX3397 + Radiation Therapy + Temozolomide in Patients With Newly Diagnosed Glioblastoma Status COMPLETED Phase PHASE1/PHASE2
NCT01765400 Platelet Inhibition in Patients With Systolic Heart Failure Status COMPLETED Phase PHASE4
NCT01756898 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT01755767 Study of Tivantinib in Subjects With Inoperable Hepatocellular Carcinoma (HCC) Who Have Been Treated With One Prior Therapy Status COMPLETED Phase PHASE3
NCT01740037 IntegRAted Chronic Care Program at Specialized AF Clinic Versus Usual CarE in Patients With Atrial Fibrillation - RACE4 Status COMPLETED Phase NA
NCT01699061 Effect of Tivantinib on the QTC Interval in Cancer Subjects Status COMPLETED Phase PHASE1
NCT01662908 A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis Status COMPLETED Phase PHASE2
NCT01611857 Phase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or Stomach Status COMPLETED Phase PHASE1/PHASE2
NCT01588678 A Open-Label, Multiple Ascending Dose Study of DS-3078a, an Oral TORC1/2 Kinase Inhibitor, in Subjects With Advanced Solid Tumors or Lymphomas Status COMPLETED Phase PHASE1
NCT01587651 Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease Status COMPLETED Phase PHASE4
NCT01582217 Patients Undergoing Percutaneous Coronary Intervention (PCI) Through Optimal Platelet Inhibition Status COMPLETED Phase N/A
NCT01565668 Open Label Study to Evaluate Safety and Efficacy of 2 Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia Status COMPLETED Phase PHASE2
NCT01552954 Effects of Low Sodium Intake on the Anti-proteinuric Efficacy in Hypertensive Patient With Olmesartan Status COMPLETED Phase PHASE4
NCT01538446 Tailored Antiplatelet Therapy Versus Recommended Dose of Prasugrel Status COMPLETED Phase PHASE4
NCT01525602 Safety Study of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01517399 Drug-drug Interaction Study of Tivantinib (ARQ 197) With Omeprazole, S-warfarin, Caffeine, Midazolam, and Digoxin in Cancer Subjects Status COMPLETED Phase PHASE1
NCT01512199 Phase 1b/2 Study of U3-1287 in Combination With Trastuzumab Plus Paclitaxel in Newly Diagnosed Metastatic Breast Cancer (MBC) Status TERMINATED Phase PHASE1/PHASE2
NCT01502631 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SUN13837 Injection in Adult Subjects With Acute Spinal Cord Injury (ASCI) Status COMPLETED Phase PHASE2